Insider Transactions in Q1 2024 at Cryoport, Inc. (CYRX)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 25
2024
|
Jerrell Shelton President, CEO |
SELL
Open market or private sale
|
Direct |
2,631
-0.38%
|
$44,727
$17.54 P/Share
|
Mar 25
2024
|
Robert Stefanovich Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,079
-0.83%
|
$18,343
$17.54 P/Share
|
Mar 25
2024
|
Mark W Sawicki Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,367
-1.73%
|
$23,239
$17.54 P/Share
|
Mar 15
2024
|
Ramkumar Mandalam Director |
SELL
Open market or private sale
|
Direct |
3,217
-6.93%
|
$45,038
$14.68 P/Share
|
Mar 15
2024
|
Ramkumar Mandalam Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+15.23%
|
$41,670
$5.4 P/Share
|
Mar 15
2024
|
Mark W Sawicki Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,750
+6.8%
|
-
|
Mar 15
2024
|
Mark W Sawicki Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,312
-1.76%
|
$19,680
$15.43 P/Share
|
Mar 15
2024
|
Robert Stefanovich Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,750
+4.25%
|
-
|
Mar 15
2024
|
Robert Stefanovich Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,035
-0.83%
|
$15,525
$15.43 P/Share
|
Mar 15
2024
|
Edward J Zecchini Chief Digital and Tech Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,455
+14.14%
|
-
|
Mar 15
2024
|
Jerrell Shelton President, CEO |
SELL
Open market or private sale
|
Direct |
57,039
-3.84%
|
$969,663
$17.92 P/Share
|
Mar 15
2024
|
Jerrell Shelton President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+11.78%
|
$400,000
$4.8 P/Share
|
Mar 15
2024
|
Jerrell Shelton President, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
14,901
+2.24%
|
-
|
Mar 15
2024
|
Linda Baddour Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,111
+4.87%
|
-
|
Mar 11
2024
|
Mark W Sawicki Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,418
-1.87%
|
$22,688
$16.35 P/Share
|
Mar 11
2024
|
Robert Stefanovich Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,119
-0.89%
|
$17,904
$16.35 P/Share
|
Mar 11
2024
|
Jerrell Shelton President, CEO |
SELL
Open market or private sale
|
Direct |
3,723
-0.58%
|
$59,568
$16.35 P/Share
|
Mar 09
2024
|
Mark W Sawicki Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,666
+3.4%
|
-
|
Mar 09
2024
|
Robert Stefanovich Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,666
+2.08%
|
-
|
Mar 09
2024
|
Jerrell Shelton President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,250
+1.27%
|
-
|